Investment
Features
FeesSafety
Academy
More
Pluang+

iShares Ethereum Trust ETF plans 1-for-3 reverse split amid mixed investor moves and Ethereum regulatory concerns

Company Fundamentals
29 Sep 2026
Gordon Thompson
View Source
Neutral
iShares Ethereum Trust ETF plans 1-for-3 reverse split amid mixed investor moves and Ethereum regulatory concerns

The iShares Ethereum Trust ETF (ETHA) will execute a 1-for-3 reverse stock split in October 2026, reducing the number of shares and potentially raising the share price. Institutional investors are divided: Squarepoint Ops LLC cut its holdings by 63.1%, signaling caution, while Macquarie Group Ltd. and Cerity Partners LLC significantly increased their stakes, showing confidence. Ethereum, the ETF's underlying asset, faces price volatility and regulatory uncertainty after the CLARITY Act failed in the Senate, affecting investor sentiment and the ETF's outlook. This mix of corporate action and market challenges highlights the varied institutional views on Ethereum exposure.

The iShares Ethereum Trust ETF (ETHA) is the subject, with Pluang market data as of Sep 29, 2026 19:33 WIB providing context. On that day, out of 150 priced US stocks tradable on Pluang, 97 rose and 48 fell. Notable movers included SPCE at USD 3.20 with a 1-day change of +1.91% and a typical hold time of 68 days, UAL at USD 113.50 with a 1-day change of +1.78% and 100% buy order activity, and AFRM at USD 68.40 with a 1-day change of +1.77%.

More News

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...

Analyst Insights
Bullish
2 hours ago
Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...

Market News
Bearish
2 hours ago
Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival Corporation reported strong quarterly results with earnings per share of $1.43 and net income of $1.92 billion, surpassing analyst expectations. The company achieved record revenue of $8.44 billion, driven by growing consumer interest in cru...

Company Fundamentals
Bullish
2 hours ago
FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet is set to report strong Q3 earnings with an expected EPS of $4.35 and revenue around $629.83 million, reflecting a 5.3% increase from last year. The company benefits from high demand for AI-related products, expanded client base, and effectiv...

Company Fundamentals
Bullish
2 hours ago
Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies Financial Group reported robust Q3 results with earnings per share of $1.09, beating analyst estimates and last year's $1.05. Revenue rose to $2.22 billion, driven by record banking revenue, surpassing expectations. Net earnings increased t...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App